COMMUNIQUÉS West-GlobeNewswire

The New England Journal of Medicine Publishes First Data to Demonstrate the Potential for Disease Modification in Dravet Syndrome
04/03/2026
–Results show that targeting the underlying cause of Dravet syndrome with zorevunersen may improve outcomes for people with this rare, devastating genetic neurodevelopmental disease– –Data support ongoing global Phase 3 [...]
Sotera Health Announces Secondary Offering of Common Stock
04/03/2026
CLEVELAND, March 04, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC) (the “Company”) today announced the launch of a secondary offering (the “Offering”) of 25 million shares of its common stock, par value $ [...]
Coloplast appoints Gavin Wood as new CEO
04/03/2026
Announcement no. 3/2026 Inside information Coloplast appoints Gavin Wood as new CEO The Coloplast Board of Directors is pleased to announce the appointment of Gavin Wood as the new President and Chief Executive Officer [...]
Bioxytran Announces Positive Dose Optimization Results and Advances Toward Phase 3 Registrational Trial for ProLectin-M
04/03/2026
Company Initiates Regulatory Discussions with CDSCO; Plans 408-Patient Pivotal Study Targeting Standard-Risk Several Viral Infected Outpatients BOSTON, March 04, 2026 (GLOBE NEWSWIRE) -- Bioxytran, Inc. (OTCQB: BIXT) [...]
Los Angeles Orthodontist McComb Orthodontics Reaches 5,000 Invisalign Cases, Earns Sapphire Status
04/03/2026
LOS ANGELES, March 04, 2026 (GLOBE NEWSWIRE) -- Invisalign provider McComb Orthodontics , a specialty orthodontic practice with clinics in West Hollywood and Culver City, has reached Sapphire status, Invisalign’s [...]
Predictors of Success for 60-Day Peripheral Nerve Stimulation (PNS) Used for Treatment of Chronic Shoulder Pain: A Multi-Center Retrospective Chart Review
04/03/2026
- Bimodal stimulation produced significantly higher shoulder pain relief compared to other stimulation paradigms - CLEVELAND, March 04, 2026 (GLOBE NEWSWIRE) -- Shoulder pain is one of the most common locations of [...]
Communiqué de presse : Dépôt d’un amendement au Document d’Enregistrement Universel 2025, contenant le Rapport Financier Annuel
04/03/2026
Dépôt d’un amendement au Document d’Enregistrement Universel 2025, contenant le Rapport Financier Annuel Paris, le 4 mars 2026 . Sanofi annonce avoir déposé ce jour un amendement à son Document d’Enregistrement [...]
FemPulse Pivotal Study Selected For Presentation at the American Urological Association Annual Conference
04/03/2026
SAN FRANCISCO, March 04, 2026 (GLOBE NEWSWIRE) -- FemPulse™, a bioelectronic medical technology company with first application overactive bladder (OAB), announced today that the Company’s pivotal clinical study was [...]
Baylor Genetics to Highlight New Data and Product Innovations at 2026 ACMG Annual Clinical Genetics Meeting
04/03/2026
Company’s exhibit theater presentation will highlight multiomic and multimodal innovations in rare disease diagnostics HOUSTON, March 04, 2026 (GLOBE NEWSWIRE) -- Baylor Genetics , a leading diagnostic genomics partner [...]
Koç University Hospital, a Koç Healthcare Institution, is Named Türkiye’s Top Hospital and Ranked Among the Newsweek–Statista World’s Best Hospitals 2026
04/03/2026
ISTANBUL, March 04, 2026 (GLOBE NEWSWIRE) -- Koç University Hospital a leading institution of Koç Healthcare has set the national benchmark for excellence in healthcare. In the recently announced 2026 edition of [...]
Can-Fite Announces Exercise of Warrants for Approximately $4.0 Million in Gross Proceeds
04/03/2026
RAMAT GAN, Israel, March 04, 2026 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF) (“Can-Fite” or the “Company”), a biotechnology company advancing a pipeline of proprietary small-molecule [...]
Compass Health Expands YGo Youth Mobile Crisis Services Across Northwest Washington
04/03/2026
YGo teams in Snohomish, Skagit, and Whatcom counties provide immediate, short-term behavioral health support for youth and families EVERETT, Wash., March 04, 2026 (GLOBE NEWSWIRE) -- Compass Health has expanded its YGo [...]
Press Release: Filing of an amendment to the French “Document d’Enregistrement Universel” containing the Annual Financial Report
04/03/2026
Filing of an amendment to the French “Document d’Enregistrement Universel” containing the Annual Financial Report Paris, March 4, 2026 . Sanofi announces today the filing of an amendment to its “Document d’ [...]
TLI Selects Higher Logic to Power Community Collaboration on the Autism Knowledge Gateway
04/03/2026
MCLEAN, Va., March 04, 2026 (GLOBE NEWSWIRE) -- The Thought Leadership & Innovation Foundation (TLI) is proud to announce its adoption of the Higher Logic platform to power community engagement and clinical [...]
Can-Fite’s Namodenoson Successfully Meets Primary Endpoint in Phase 2a Pancreatic Cancer Study
04/03/2026
Ramat Gan, Israel, March 04, 2026 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a clinical-stage biotechnology company developing a pipeline of proprietary small molecule drugs for the [...]
EDAP to Announce Fourth Quarter and Full Year 2025 Financial Results on March 25, 2026
04/03/2026
EDAP to Announce Fourth Quarter and Full Year 2025 Financial Results on March 25, 2026 Company to host conference call and webcast on Wednesday, March 25 at 8:30 a.m. EDT AUSTIN, Texas, March 4, 2026 -- EDAP TMS SA ( [...]
Cellectar Biosciences Reports Financial Results for Year Ended 2025 and Provides Corporate Updates
04/03/2026
On track to submit Conditional Marketing Authorization for iopofosine I 131 to European Medicines Agency in Q3 2026 for potential 2027 EU commercialization as a treatment for Waldenström Macroglobulinemia Initiated [...]
Dyadic and Fermbox Bio Launch First Product Under Expanded Collaboration: Animal-Origin-Free Recombinant DNase I (RNase-Free)
04/03/2026
JUPITER, Fla. and BENGALURU, India, March 04, 2026 (GLOBE NEWSWIRE) -- Dyadic Applied BioSolutions (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company producing precision- [...]
Rezolute to Participate in the Citizens Life Sciences Conference
04/03/2026
REDWOOD CITY, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage rare disease company focused on treating hypoglycemia caused by all forms of [...]

Pages